A nasal spray can look familiar while containing an inadequately characterized drug product. The delivery route does not establish safety, predictable absorption or an appropriate clinical indication. This is particularly important for melanotan products marketed for tanning.

What recent regulator testing found

In August 2026, Australia's Therapeutic Goods Administration reported laboratory findings from seized melanotan II nasal products. The tested bottles did not contain consistent amounts of the advertised substance. The regulator warned against their use and explained that no melanotan II products were included in Australia's therapeutic goods register or approved for supply there. Those findings concern the tested products and Australian regulation; they are not a measurement of every product worldwide. TGA laboratory findings on melanotan II nasal products

The study of a molecule is also different from verification of a finished spray. Container delivery, formulation, stability and the accuracy of its contents can each affect exposure. A certificate for a raw ingredient does not answer all of those questions.

Do not borrow another medicine's approval

Afamelanotide is the active ingredient in Scenesse, a prescription implant approved for a specific use in adults with erythropoietic protoporphyria. That indication and formulation do not establish that a melanotan nasal spray is approved, interchangeable or suitable for cosmetic tanning. FDA Scenesse prescribing information

Photographs of a darker complexion cannot show whether a product is safe over time. They also cannot establish protection against ultraviolet injury. A medical claim needs evidence that matches the actual product, route, population and outcome, a principle reflected in FTC substantiation guidance. FTC Health Products Compliance Guidance

For AXON, the useful educational focus is the gap between a familiar-looking package and verified clinical evidence. This article does not provide a nasal-use protocol, a tanning plan or a supplier recommendation. Changes in moles or unexplained skin symptoms warrant professional assessment rather than interpretation through a seller's before-and-after gallery.